The origin of the myofibroblast in fibroproliferative vasculopathy: Does the endothelial cell steer the pathophysiology of systemic sclerosis?

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2164-2167

  Manetti, Mirko ^a   Guiducci, Serena ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCOGEN SYNTHASE KINASE 3BETA; IMATINIB; PROTEIN KINASE C DELTA; ROTTLERIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROPROLIFERATIVE VASCULOPATHY; FIBROSIS; HUMAN; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ENDOTHELIAL CELLS; HUMANS; MYOFIBROBLASTS; SCLERODERMA, SYSTEMIC;

EID: 79961103549     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30316     Document Type: Review

References (29)

1. Eyden B,. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008; 12: 22-37. (Pubitemid 351430454)
2. Varga J, Abraham D,. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-67. (Pubitemid 46348510)
3. Gabrielli A, Avvedimento EV, Krieg T,. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
4. Guiducci S, Giacomelli R, Matucci-Cerinic M,. Vascular complications of scleroderma. Autoimmun Rev 2007; 6: 520-3. (Pubitemid 47374612)
5. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J,. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 2011; 10: 267-75.
6. Ong VH, Denton CP,. Innovative therapies for systemic sclerosis. Curr Opin Rheumatol 2010; 22: 264-72.
7. Leask A,. Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment. Fibrogenesis Tissue Repair 2010; 3: 8.
8. Kalluri R, Neilson EG,. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-84. (Pubitemid 38063698)
9. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952-61. (Pubitemid 47222040)
10. Chaudhuri V, Zhou L, Karasek M,. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol 2007; 34: 146-53. (Pubitemid 46145554)
11. Arciniegas E, Frid MG, Douglas IS, Stenmark KR,. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1-8. (Pubitemid 47080705)
12. Goumans MJ, van Zonneveld AJ, ten Dijke P,. Transforming growth factor β-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc Med 2008; 18: 293-8.
13. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R,. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-7.
14. Kizu A, Medici D, Kalluri R,. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 2009; 175: 1371-3.
15. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43: 161-72.
16. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R,. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007; 67: 10123-8. (Pubitemid 350070783)
17. Ishisaki A, Hayashi H, Li AJ, Imamura T,. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 2003; 2782: 1303-9. (Pubitemid 36790814)
18. Frid MG, Kale VA, Stenmark KR,. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002; 90: 1189-96. (Pubitemid 34786904)
19. Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K,. Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 2008; 121: 3317-24.
20. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
21. Massague J, Gomis RR,. The logic of TGFβ signaling. FEBS Lett 2006; 580: 2811-20.
22. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 2003; 425: 577-84. (Pubitemid 37280136)
23. Li Z, Jimenez SA,. Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial- mesenchymal transition in vitro. Arthritis Rheum 2011; 63: 2473-83.
24. Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 2007; 56: 311-22. (Pubitemid 46106205)
25. Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, et al. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum 2009; 60: 219-24.
26. Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2005; 171: 1279-85. (Pubitemid 40740736)
27. Jimenez SA, Gaidarova S, Saitta B, Sandorfi N, Herrich DJ, Rosenbloom JC, et al. Role of protein kinase C-δ in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 2001; 108: 1395-403. (Pubitemid 33107768)
28. Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial- to-mesenchymal transition. Circulation 2010; 121: 2407-18.
29. Xu H, Zaidi M, Struve J, Jones DW, Krolikowski JG, Nandekar S, et al. Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. Am J Physiol Cell Physiol 2011; 300: C550-6.